Sort
51,570 grants matching “autoimmune disease”
Libby Epidemiology Research Program
$965,000Stephen Michael Levin · Icahn School Of Medicine At Mount Sinai · R01 · FY2009 · TS
Libby Epidemiology Research Program
$965,000Jaime Szeinuk · Icahn School Of Medicine At Mount Sinai · R01 · FY2011 · TS
Libby Epidemiology Research Program
$965,000Raja M Flores · Icahn School Of Medicine At Mount Sinai · R01 · FY2012 · TS
Libby Epidemiology Research Program
$965,000Stephen Michael Levin · Icahn School Of Medicine At Mount Sinai · R01 · FY2010 · TS
Libby Epidemiology Research Program
$965,000Raja M. Flores · Icahn School Of Medicine At Mount Sinai · R01 · FY2013 · TS
A Phase II Trial of Rituximab In Myasthenia Gravis
$964,955Richard Nowak · Yale University · U01 · FY2016 · NS
Studies of Thyroid Function in Health and Disease
$964,947Monica Skarulis · National Institute Of Diabetes And Digestive And Kidney Diseases · Z01 · FY2008 · DK
Hematopathology Diagnosis
$964,476Elaine Jaffe · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Flow cytometry support to research in immune, skin, muscle and bone diseases
$963,985Massimo Gadina · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIC · FY2016 · AR
Targeting Multiple Diseases Through Gamma Secretase
$963,895Barbara A Osborne · University Of Massachusetts Amherst · P01 · FY2007 · AG
Gene Regulation as a Foundation for Autoimmune Disease Prevention
$963,738Matthew Tyson Weirauch · Cincinnati Childrens Hosp Med Ctr · U01 · FY2021 · AI
Unraveling Cytotoxic and Thrombotic Signals in COVID-19
$963,672Yogen Kanthi · National Heart, Lung, And Blood Institute · ZIA · FY2022 · HL
Convenient quantification of myopathic change in muscle via electrical impedance myography
$963,608David P. Dickinson · Myolex, Inc. · R44 · FY2025 · AR
Targeted Lymphoablation as an alternative to HSCT to cure T1D
$963,581Theresa Deisher · Avm Biotechnology, Llc · R44 · FY2023 · DK
Distinct contributions of CCR4 versus CCR7 to thymocyte localization and central tolerance
$963,188Lauren Ilyse Richie Ehrlich · University Of Texas At Austin · R01 · FY2020 · AI
Molecular Drivers of Atherosclerosis in Diabetes
$962,975Mete Civelek · University Of Virginia · U01 · FY2024 · DK
Safe and effective anti CD154 antibodies for therapeutic intervention
$962,696Matthew F. Mackey · Immunext, Inc. · R44 · FY2014 · AI
Protein-Glycan Interaction Resource at the National Center for Functional Glycomics (NCFG)
$962,500Richard D Cummings · Beth Israel Deaconess Medical Center · R24 · FY2023 · GM
Protein-Glycan Interaction Resource at the National Center for Functional Glycomics (NCFG)
$962,500Richard D Cummings · Beth Israel Deaconess Medical Center · R24 · FY2024 · GM
Protein-Glycan Interaction Resource at the National Center for Functional Glycomics (NCFG)
$962,500Richard D Cummings · Beth Israel Deaconess Medical Center · R24 · FY2022 · GM
Protein-Glycan Interaction Resource at the National Center for Functional Glycomics (NCFG)
$962,500Richard D Cummings · Beth Israel Deaconess Medical Center · R24 · FY2021 · GM
Genetics and pathophysiology of systemic lupus erythematosus in global populations
$962,305Laura Lewandowski · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2023 · AR
IMMUNOGENETIC MECHANISMS OF EXPERIMENTAL CROHN'S DISEASE
$962,000University Of Virginia Charlottesville · P01 · FY2000 · DK
Production of antibody therapeutic fragments by reduced genome E. coli in continuous culture
$961,744Frederick R Blattner · Scarab Genomics, Llc · R44 · FY2022 · AI
REPTOR: accelerating antibody discovery and improving hits with machine learning
$961,244Natalie Castellana · Abterra Biosciences, Inc. · R44 · FY2025 · GM